Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 1/2010

01-05-2010 | Poster presentation

Predicting interaction networks of breast cancer risk genes using multiple microarray data

Author: K Yano

Published in: Breast Cancer Research | Special Issue 1/2010

Login to get access

Excerpt

Global expression profiling by microarray can provide invaluable information about biological properties of breast cancers. Here I report predicted gene regulatory networks of known breast cancer risk genes using multiple microarray data, in order to understand how the risk genes interact with each other and how the interaction may be related to the pathogenesis of breast cancer. …
Metadata
Title
Predicting interaction networks of breast cancer risk genes using multiple microarray data
Author
K Yano
Publication date
01-05-2010
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 1/2010
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2540

Other articles of this Special Issue 1/2010

Breast Cancer Research 1/2010 Go to the issue

Poster presentation

FKBPL: a novel prognostic and predictive biomarker?

Poster presentation

Mitochondrial translocator protein modulates metabolism and pharmacologically induced apoptosis in breast cancer cells

Poster presentation

Genetic engineering of pharmacologically regulated T cells, specific for breast cancer target antigens

Poster presentation

Breast cancer knowledge among women with learning disabilities and their experiences of breast mammography

Poster presentation

CYP2D6 genotype affects outcome in postmenopausal breast cancer patients treated with tamoxifen monotherapy

Poster presentation

Could side population cells be an indicator of progression to hormone nonresponsive breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits